Back
CRISPR Therapeutics AG Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
CRSP
CRISPR Therapeutics AG
Last Price:
$38.28
Seasonality Move:
20.1%
7 Day Trial
ALL ACCESS PASS
$
7
CRISPR Therapeutics AG Stock Forecast
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 32.6% based on the past 8 years of stock performance.
-
CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is CRISPR Therapeutics AG Stock Undervalued?The current CRISPR Therapeutics AG [CRSP] share price is $38.27. The Score for CRSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will CRISPR Therapeutics AG Stock Go Up Next Year?
-
Over the next 52 weeks, CRISPR Therapeutics AG has on average historically risen by 32.6% based on the past 8 years of stock performance.
CRISPR Therapeutics AG Stock Rating
Sell
34
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG overpriced?
-
CRISPR Therapeutics AG has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
CRISPR Therapeutics AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
crisprtx.com
52-Week Data
52-Week High:
67.88
52-Week Low:
30.04
Prediction Charts
Market Cap:
3.3B
Price in USD:
38.27
Volume:
1.3M
Beta:
2.04
Technical Analysis
SMA50:
40.71
SMA100:
42.02
SMA200:
45.82
52-Wk Change:
-28.77%
Stock Predictions
-
Is CRISPR Therapeutics AG stock public?Yes, CRISPR Therapeutics AG is a publicly traded company.
-
What is the CRISPR Therapeutics AG stock quote today?The CRISPR Therapeutics AG stock price is 38.27 USD today.
-
How to buy CRISPR Therapeutics AG stock online?You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-7 | 30.88 | 32.38 | 34.22 | 30.04 |
| Apr-8 | 34.65 | 31.27 | 35.38 | 30.87 |
| Apr-9 | 30.56 | 34.89 | 35.06 | 30.52 |
| Apr-10 | 34.01 | 34.26 | 34.77 | 32.90 |
| Apr-11 | 34.44 | 39.30 | 39.30 | 34.44 |
| Apr-14 | 40.00 | 38.81 | 40.13 | 37.62 |
| Apr-15 | 38.42 | 38.95 | 39.89 | 38.27 |
| Apr-16 | 38.43 | 37.78 | 38.50 | 36.74 |
| Apr-17 | 37.23 | 37.77 | 38.22 | 37.23 |
| Apr-21 | 37.06 | 37.82 | 39.27 | 36.66 |
| Apr-22 | 38.49 | 39.23 | 39.85 | 38.34 |
| Apr-23 | 40.11 | 38.54 | 40.73 | 38.54 |
| Apr-24 | 38.73 | 39.11 | 39.35 | 38.25 |
| Apr-25 | 38.73 | 38.27 | 39.05 | 37.93 |
CRISPR Therapeutics AG Earnings
CRISPR Therapeutics AG Earnings Report: Per Share CRISPR Therapeutics AG Earnings Q1 Q2 Q3 and Q4 last year and next year.
CRISPR Therapeutics AG Forecast Revenue Growth
CRISPR Therapeutics AG Stock Analysis: Historical quarterly revenues per share for CRISPR Therapeutics AG and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.94 per share.
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.